Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia
Clinical trial NCT04541186 · COMPLETED
Trial details
- NCT number
- NCT04541186
- Sponsor
- 89bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-05-19
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.